Hello Kranky,what you have just done is regurgitate exactly what...

Hello Kranky,

what you have just done is regurgitate exactly what ECT had disclosed to it's shareholders in their ASX Ann. "Shareholder Update" Pg 3-dated 15.06.2012. "There has been considerable discussion about the use of equity....."

All you have done is lace the subject of dilution with your concerns as a non SH. There is no surprise to us SH's in what you have stated in your post. All you seem to be doing is raising alarm bells on a deal that has not been completed. There are also alot if "if's" in the points of concern you raise. It's as informative as telling SH's what the SP was on a certain day-we can all get that information from the ASX website.

There seems to be a trend being established by you. I was more than happy to collaborate and inform posters such as yourself, but to be honest I am growing tired of what I am reading recently. It's always a case of DYOR, and if interested become a SH.

These posts are continually going in circles on points to subject connected to deals that have not been completed yet. Being a Spec stock it will be risk vs reward.

If you think that ECT are interested in securing $4m to complete DFT 2&3 and provide working capital only, (effectively paperwork and patents) and this will be the end of the ECT story then I suggest you move on. For the rest of us, as SH's we see a different picture forming. This last part in IMHO.

Best of luck to all.